Bad behavior rampant - Recensione dipendente - Dipendente anonimo presso SynCardia Systems

1,0
2 ago 2015
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The product is incredible. Patient stories are inspiring.

Svantaggi

Too many to list. Employees are essentially slaves to their managers. All management lacks accountability. The company does not encourage growth or career development in any regard. Harassment, hostility and humiliation are the management tools used to "motivate" throughout the company. The CEO actively humiliates individuals for mistakes, threatens to fire people often... Usually only fires people who have no ability fight back, keeps the management sociopaths who abuse their employees. Do NOT work here, run.

Esplora altre recensioni su SynCardia Systems

5,0
16 apr 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Always looking to improve company processes

Svantaggi

Company history has a lack of funding

1,0
1 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Decent pay, middle management didn't hover, honorable product

Svantaggi

1. Quality management system needs an update and an overhaul. Document control, procedures, forms, their system is unnecessarily convoluted, vague, and difficult to navigate. Good luck getting trained on it either, everything was self taught and you learned by completing something and having quality tell you you did it wrong. 2. Terrible marketing, low sales, and little to no effort into expanding their market. C suite complained about lack of income and low sales but they were making no effort to onboard additional hospitals and centers, and no effort to train additional surgical teams on the transplant procedure. There will be a cap on the number of hearts you sell if there are only 4 surgeons in the country who can perform the implant. 3. Poor financial decision making. Rather than investing in sales, marketing, and onboarding additional hospitals and surgeons to increase heart sales, the financial priority was working on a replacement product which with delay after delay and how slow development goes on medical devices unfortunately caused them to bleed money even faster and lead to this round of lay-offs (June 2026).

Vedi recensioni per: Utile|Valutazione|Data|Tutto